| Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine C Chakraborty, AR Sharma, G Sharma, CGP Doss, SS Lee Molecular Therapy-Nucleic Acids 8, 132-143, 2017 | 843 | 2017 |
| Development of epitope‐based peptide vaccine against novel Coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach M Bhattacharya, A Ranjan Sharma, P Patra, P Ghosh, G Sharma, ... Journal of Medical Virology, 2020 | 408 | 2020 |
| SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options C CHAKRABORTY, AR SHARMA, G SHARMA, M BHATTACHARYA, ... European Review for Medical and Pharmacological Sciences 24, 4016-4026, 2020 | 354 | 2020 |
| Therapeutic advances of miRNAs: A preclinical and clinical update C Chakraborty, AR Sharma, G Sharma, SS Lee Journal of Advanced Research 28, 127-138, 2021 | 341 | 2021 |
| Zebrafish: A complete animal model to enumerate the nanoparticle toxicity C Chakraborty, AR Sharma, G Sharma, SS Lee Journal of nanobiotechnology 14, 1-13, 2016 | 339 | 2016 |
| Zebrafish: a complete animal model for in vivo drug discovery and development C Chakraborty, CH Hsu, ZH Wen, CS Lin, G Agoramoorthy Current drug metabolism 10 (2), 116-124, 2009 | 334 | 2009 |
| Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes C Chakraborty, C Doss, S Bandyopadhyay, G Agoramoorthy Wiley Interdisciplinary Reviews: RNA 5 (5), 697-712, 2014 | 271 | 2014 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 251 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 222 | 2024 |
| CRISPR-Cas9: a preclinical and clinical perspective for the treatment of human diseases G Sharma, AR Sharma, M Bhattacharya, SS Lee, C Chakraborty Molecular therapy 29 (2), 571-586, 2021 | 212 | 2021 |
| Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes G Sharma, AR Sharma, JS Nam, GPC Doss, SS Lee, C Chakraborty Journal of nanobiotechnology 13, 1-13, 2015 | 206 | 2015 |
| Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies K Dhama, F Nainu, A Frediansyah, MI Yatoo, RK Mohapatra, ... Journal of infection and public health 16 (1), 4-14, 2023 | 203 | 2023 |
| A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies S Chatterjee, M Bhattacharya, S Nag, K Dhama, C Chakraborty Viruses 15 (1), 167, 2023 | 201 | 2023 |
| Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine JS Nam, AR Sharma, LT Nguyen, C Chakraborty, G Sharma, SS Lee Molecules 21 (1), 108, 2016 | 193 | 2016 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 185 | 2024 |
| Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier G Sharma, AR Sharma, SS Lee, M Bhattacharya, JS Nam, C Chakraborty International Journal of Pharmaceutics 559, 360-372, 2019 | 179 | 2019 |
| Probable molecular mechanism of remdesivir for the treatment of COVID-19: need to know more A Saha, AR Sharma, M Bhattacharya, G Sharma, SS Lee, C Chakraborty Archives of Medical research 51 (6), 585, 2020 | 167 | 2020 |
| Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis LT Nguyen, AR Sharma, C Chakraborty, B Saibaba, ME Ahn, SS Lee International journal of molecular sciences 18 (3), 601, 2017 | 144 | 2017 |
| The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies C Chakraborty, AR Sharma, M Bhattacharya, G Agoramoorthy, SS Lee Frontiers in pharmacology 12, 704205, 2021 | 138 | 2021 |
| Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19 RP Saha, AR Sharma, MK Singh, S Samanta, S Bhakta, S Mandal, ... Frontiers in pharmacology 11, 1258, 2020 | 130 | 2020 |
Manojit Bhattacharya. Ph.DAssistant Professor of Zoology, Fakir Mohan UniversityVerified email at sc.fmuniversity.in
